Olfactomics

Executive Summary

Olfactomics is a Finnish deeptech company founded in 2020, specializing in advanced gas sensing solutions for medical and industrial applications. Its core innovation is a proprietary differential ion mobility spectrometer (DMS) that detects volatile organic compounds (VOCs) at parts-per-billion levels in milliseconds. The company combines this highly sensitive hardware with artificial intelligence and machine learning to deliver real-time, accurate measurements of odors, aromas, and scents. In the medical field, Olfactomics' technology has potential for non-invasive disease diagnosis through breath analysis, while industrial applications include quality control, environmental monitoring, and process optimization. The company's platform addresses a growing need for portable, rapid, and sensitive detection systems across multiple sectors. As an early-stage private company headquartered in Helsinki, Olfactomics is positioned at the intersection of diagnostics and AI, targeting markets that demand precision and speed. While specific funding and revenue details are not publicly disclosed, the company's technology has attracted interest from healthcare and industrial players. Future growth will depend on successful validation of its DMS platform in clinical settings, strategic partnerships for commercialization, and securing capital to scale operations. With the global VOC sensor market expanding and increasing demand for non-invasive diagnostics, Olfactomics could become a key player if it executes effectively on its technology roadmap.

Upcoming Catalysts (preview)

• Q1 2027Clinical validation results from breath analysis studies45% success
• Q2 2027Strategic partnership with a diagnostics or industrial quality control firm50% success
• Q4 2026Series A funding round closure60% success